This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the creation of molecules that target specific biological pathways, often in the context of central nervous system disorders or inflammatory conditions. Its trifluoromethyl pyridine moiety enhances the bioavailability and metabolic stability of the resulting drugs. Additionally, it is employed in the development of small-molecule inhibitors for various enzymes and receptors, contributing to the advancement of treatments for complex diseases. Its dihydrochloride form ensures improved solubility and handling in laboratory settings.